Diabetic ketoacidosis in an HIV patient : a new mechanism of HIV protease inhibitor-induced glucose intolerance
Several medications used in HIV care such as didanosine, pentamidine, corticosteroids, megastrol acetate, and protease inhibitors have been associated with hyperglycemia. We report a case of severe hyperglycemic decompensation and propose a possible mechanism.
Gespeichert in:
| Veröffentlicht in: | AIDS (London) 1999-10, Vol.13 (14), p.1987-1989 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1989 |
|---|---|
| container_issue | 14 |
| container_start_page | 1987 |
| container_title | AIDS (London) |
| container_volume | 13 |
| creator | KAN, V. L NYLEN, E. S |
| description | Several medications used in HIV care such as didanosine, pentamidine, corticosteroids, megastrol acetate, and protease inhibitors have been associated with hyperglycemia. We report a case of severe hyperglycemic decompensation and propose a possible mechanism. |
| doi_str_mv | 10.1097/00002030-199910010-00029 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17405006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17405006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-14263457932054abead83bc32eb383ff779c214276f8f1a5094effa7d5d0661e3</originalsourceid><addsrcrecordid>eNpNkM1O7SAUhYm5Ro8_r2AY3NxZdVMKFGfG_8TEiTptKN0o2hYtNMa3l-M5Xt0Tks23YOUjhDI4ZKDVEeQpgUPBtNYMgEGx3OgNsmCV4oUQiv0hCyilLjRXsE12YnzOiIC63iLbDATjUooFCWfetJi8pS-YgrG-C9FH6kdqRnp1_UBfTfI4JnpMDR3xnQ5on8zo40CDWwFTSGgi5syTb30KU-HHbrbY0cd-tuHrJoUeJzNa3CObzvQR99fnLrm_OL87vSpubi-vT09uCss1pIJVpeSVUJqXIKrc0HQ1by0vseU1d04pbcsMKelqx4wAXaFzRnWiAykZ8l3yb_Vurvc2Y0zN4KPFvjcjhjk2TFVZBsgM1ivQTiHGCV3zOvnBTB8Ng2Ypu_mW3fyX3XzJztGD9R9zO2D3K7iym4G_a8BEa3q3NODjD6c1aKn4J_NNhqo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17405006</pqid></control><display><type>article</type><title>Diabetic ketoacidosis in an HIV patient : a new mechanism of HIV protease inhibitor-induced glucose intolerance</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>KAN, V. L ; NYLEN, E. S</creator><creatorcontrib>KAN, V. L ; NYLEN, E. S</creatorcontrib><description>Several medications used in HIV care such as didanosine, pentamidine, corticosteroids, megastrol acetate, and protease inhibitors have been associated with hyperglycemia. We report a case of severe hyperglycemic decompensation and propose a possible mechanism.</description><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/00002030-199910010-00029</identifier><identifier>PMID: 10513665</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Biological and medical sciences ; Diabetic Ketoacidosis - chemically induced ; Drug Therapy, Combination ; Drug toxicity and drugs side effects treatment ; Glucose Intolerance - chemically induced ; Glucose Intolerance - drug therapy ; HIV Infections - complications ; HIV Infections - drug therapy ; HIV Protease Inhibitors - adverse effects ; HIV Protease Inhibitors - therapeutic use ; Human immunodeficiency virus ; Human immunodeficiency virus 1 ; Humans ; Indinavir - adverse effects ; Indinavir - therapeutic use ; Lamivudine - therapeutic use ; Male ; Medical sciences ; megestrol acetate ; Middle Aged ; Miscellaneous (drug allergy, mutagens, teratogens...) ; pentamidine ; Pharmacology. Drug treatments ; proteinase inhibitors ; Reverse Transcriptase Inhibitors - therapeutic use ; Stavudine - therapeutic use</subject><ispartof>AIDS (London), 1999-10, Vol.13 (14), p.1987-1989</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-14263457932054abead83bc32eb383ff779c214276f8f1a5094effa7d5d0661e3</citedby><cites>FETCH-LOGICAL-c390t-14263457932054abead83bc32eb383ff779c214276f8f1a5094effa7d5d0661e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1990967$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10513665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KAN, V. L</creatorcontrib><creatorcontrib>NYLEN, E. S</creatorcontrib><title>Diabetic ketoacidosis in an HIV patient : a new mechanism of HIV protease inhibitor-induced glucose intolerance</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><description>Several medications used in HIV care such as didanosine, pentamidine, corticosteroids, megastrol acetate, and protease inhibitors have been associated with hyperglycemia. We report a case of severe hyperglycemic decompensation and propose a possible mechanism.</description><subject>Biological and medical sciences</subject><subject>Diabetic Ketoacidosis - chemically induced</subject><subject>Drug Therapy, Combination</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Glucose Intolerance - chemically induced</subject><subject>Glucose Intolerance - drug therapy</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Protease Inhibitors - adverse effects</subject><subject>HIV Protease Inhibitors - therapeutic use</subject><subject>Human immunodeficiency virus</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Indinavir - adverse effects</subject><subject>Indinavir - therapeutic use</subject><subject>Lamivudine - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>megestrol acetate</subject><subject>Middle Aged</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>pentamidine</subject><subject>Pharmacology. Drug treatments</subject><subject>proteinase inhibitors</subject><subject>Reverse Transcriptase Inhibitors - therapeutic use</subject><subject>Stavudine - therapeutic use</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkM1O7SAUhYm5Ro8_r2AY3NxZdVMKFGfG_8TEiTptKN0o2hYtNMa3l-M5Xt0Tks23YOUjhDI4ZKDVEeQpgUPBtNYMgEGx3OgNsmCV4oUQiv0hCyilLjRXsE12YnzOiIC63iLbDATjUooFCWfetJi8pS-YgrG-C9FH6kdqRnp1_UBfTfI4JnpMDR3xnQ5on8zo40CDWwFTSGgi5syTb30KU-HHbrbY0cd-tuHrJoUeJzNa3CObzvQR99fnLrm_OL87vSpubi-vT09uCss1pIJVpeSVUJqXIKrc0HQ1by0vseU1d04pbcsMKelqx4wAXaFzRnWiAykZ8l3yb_Vurvc2Y0zN4KPFvjcjhjk2TFVZBsgM1ivQTiHGCV3zOvnBTB8Ng2Ypu_mW3fyX3XzJztGD9R9zO2D3K7iym4G_a8BEa3q3NODjD6c1aKn4J_NNhqo</recordid><startdate>19991001</startdate><enddate>19991001</enddate><creator>KAN, V. L</creator><creator>NYLEN, E. S</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>19991001</creationdate><title>Diabetic ketoacidosis in an HIV patient : a new mechanism of HIV protease inhibitor-induced glucose intolerance</title><author>KAN, V. L ; NYLEN, E. S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-14263457932054abead83bc32eb383ff779c214276f8f1a5094effa7d5d0661e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Diabetic Ketoacidosis - chemically induced</topic><topic>Drug Therapy, Combination</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Glucose Intolerance - chemically induced</topic><topic>Glucose Intolerance - drug therapy</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Protease Inhibitors - adverse effects</topic><topic>HIV Protease Inhibitors - therapeutic use</topic><topic>Human immunodeficiency virus</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Indinavir - adverse effects</topic><topic>Indinavir - therapeutic use</topic><topic>Lamivudine - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>megestrol acetate</topic><topic>Middle Aged</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>pentamidine</topic><topic>Pharmacology. Drug treatments</topic><topic>proteinase inhibitors</topic><topic>Reverse Transcriptase Inhibitors - therapeutic use</topic><topic>Stavudine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KAN, V. L</creatorcontrib><creatorcontrib>NYLEN, E. S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KAN, V. L</au><au>NYLEN, E. S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diabetic ketoacidosis in an HIV patient : a new mechanism of HIV protease inhibitor-induced glucose intolerance</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>1999-10-01</date><risdate>1999</risdate><volume>13</volume><issue>14</issue><spage>1987</spage><epage>1989</epage><pages>1987-1989</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><abstract>Several medications used in HIV care such as didanosine, pentamidine, corticosteroids, megastrol acetate, and protease inhibitors have been associated with hyperglycemia. We report a case of severe hyperglycemic decompensation and propose a possible mechanism.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>10513665</pmid><doi>10.1097/00002030-199910010-00029</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-9370 |
| ispartof | AIDS (London), 1999-10, Vol.13 (14), p.1987-1989 |
| issn | 0269-9370 1473-5571 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_17405006 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
| subjects | Biological and medical sciences Diabetic Ketoacidosis - chemically induced Drug Therapy, Combination Drug toxicity and drugs side effects treatment Glucose Intolerance - chemically induced Glucose Intolerance - drug therapy HIV Infections - complications HIV Infections - drug therapy HIV Protease Inhibitors - adverse effects HIV Protease Inhibitors - therapeutic use Human immunodeficiency virus Human immunodeficiency virus 1 Humans Indinavir - adverse effects Indinavir - therapeutic use Lamivudine - therapeutic use Male Medical sciences megestrol acetate Middle Aged Miscellaneous (drug allergy, mutagens, teratogens...) pentamidine Pharmacology. Drug treatments proteinase inhibitors Reverse Transcriptase Inhibitors - therapeutic use Stavudine - therapeutic use |
| title | Diabetic ketoacidosis in an HIV patient : a new mechanism of HIV protease inhibitor-induced glucose intolerance |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T17%3A06%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diabetic%20ketoacidosis%20in%20an%20HIV%20patient%20:%20a%20new%20mechanism%20of%20HIV%20protease%20inhibitor-induced%20glucose%20intolerance&rft.jtitle=AIDS%20(London)&rft.au=KAN,%20V.%20L&rft.date=1999-10-01&rft.volume=13&rft.issue=14&rft.spage=1987&rft.epage=1989&rft.pages=1987-1989&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/00002030-199910010-00029&rft_dat=%3Cproquest_cross%3E17405006%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17405006&rft_id=info:pmid/10513665&rfr_iscdi=true |